PRESCRIBING · PART D · 2024
Total Rx claims
98
Beneficiaries
—
Total drug cost
$569K
Distinct drugs
7
Brand share
48.0%
Top prescribed drugs
Imatinib Mesylate27 claims
Nilotinib Hcl13 claims
Acyclovir13 claims
Ruxolitinib Phosphate12 claims
Omeprazole11 claims
QUALITY · MIPS · 2024
Final MIPS score
99.1
Quality
84.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.01%
APM Entity
REFERRAL NETWORK
Where Bryon Allen's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Marc Gosselin Diagnostic Radiology · Dallas, TX | 17 | 71 |
| PRIMACK, STEVEN | 15 | 64 |
| GAJEWSKI, JAMES | 15 | 186 |
| BRAZIEL, RITA | 15 | 50 |
| Elie Traer Hematology-Oncology · Portland, OR | 14 | 186 |
| Charles Henrikson Clinical Cardiac Electrophysiology · Portland, OR | 12 | 32 |
| Cristina Fuss Diagnostic Radiology · Portland, OR | 12 | 53 |
| Richard Maziarz Hematology-Oncology · Portland, OR | 11 | 91 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE